A detailed history of Boone Capital Management LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Boone Capital Management LLC holds 495,089 shares of AMPH stock, worth $25.1 Million. This represents 5.17% of its overall portfolio holdings.

Number of Shares
495,089
Previous 606,688 18.39%
Holding current value
$25.1 Million
Previous $26.6 Billion 25.66%
% of portfolio
5.17%
Previous 5.39%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$38.65 - $43.48 $4.31 Million - $4.85 Million
-111,599 Reduced 18.39%
495,089 $19.8 Billion
Q1 2024

May 15, 2024

BUY
$42.85 - $63.45 $8.86 Million - $13.1 Million
206,688 Added 51.67%
606,688 $26.6 Billion
Q4 2023

Feb 14, 2024

BUY
$44.49 - $62.93 $17.8 Million - $25.2 Million
400,000 New
400,000 $24.7 Billion

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.49B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Boone Capital Management LLC Portfolio

Follow Boone Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boone Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boone Capital Management LLC with notifications on news.